首页> 美国卫生研究院文献>other >N-(2-Methyl-6-benzoxazolyl)-N′-15-n aphthyridin-4-yl urea (SB334867) a hypocretin receptor-1 antagonist preferentially prevents ethanol seeking: comparison with natural reward seeking
【2h】

N-(2-Methyl-6-benzoxazolyl)-N′-15-n aphthyridin-4-yl urea (SB334867) a hypocretin receptor-1 antagonist preferentially prevents ethanol seeking: comparison with natural reward seeking

机译:N-(2-甲基-6-苯并恶唑基)-N-15-N戊素蛋白-4-基脲(SB334867)一种绒毛素受体-1拮抗剂优先预防乙醇寻求:与自然奖励寻求比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Orexins/hypocretins (Orx/Hcrt) are hypothalamic peptides that regulate a wide range of physiological processes and have been shown to be recruited by drugs of abuse. This study was designed to test the effect of the specific Orx/Hcrt receptor-1 (Hcrt-r1) antagonist SB334867 on reinstatement elicited by ethanol (EtOH)-associated stimuli vs. stimuli associated with a conventional reinforcer (i.e., SuperSac: consisting to 3% glucose and 0.125% saccharin w/v). SB334867 (1–10 mg/kg, IP) dose-dependently reduced reinstatement induced by the EtOH- but not SuperSac-associated stimuli. These findings support a differential role of Hcrt-r1 in mediating EtOH seeking vs. natural reward seeking.
机译:食欲素/促胰泌素(Orx / Hcrt)是下丘脑肽,可调节广泛的生理过程,并已被证明可被滥用药物招募。这项研究旨在测试特异性Orx / Hcrt受体1(Hcrt-r1)拮抗剂SB334867对乙醇(EtOH)相关刺激与常规增强剂相关刺激的恢复作用(即SuperSac: 3%葡萄糖和0.125%糖精w / v)。 SB334867(1-10 mg / kg,IP)剂量依赖性地降低了EtOH-而不是SuperSac相关刺激诱导的恢复。这些发现支持Hcrt-r1在介导EtOH寻求与自然奖赏寻求之间的不同作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号